130 related articles for article (PubMed ID: 21425752)
1. FDA approves quadrivalent HPV vaccine for use in males ages 9-26 years.
Garg A; Guez G
Dent Implantol Update; 2011 Mar; 22(3):23-4. PubMed ID: 21425752
[No Abstract] [Full Text] [Related]
2. Cervarix--a second HPV vaccine.
Med Lett Drugs Ther; 2010 May; 52(1338):37-8. PubMed ID: 20467355
[No Abstract] [Full Text] [Related]
3. New indication approved for HPV vaccine.
AIDS Patient Care STDS; 2011 Feb; 25(2):127. PubMed ID: 21370548
[No Abstract] [Full Text] [Related]
4. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):630-2. PubMed ID: 20508594
[TBL] [Abstract][Full Text] [Related]
5. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):626-9. PubMed ID: 20508593
[TBL] [Abstract][Full Text] [Related]
6. The prophylactic role for the human papillomavirus quadrivalent vaccine in males.
Yancey AM; Pitlick JM; Forinash AB
Ann Pharmacother; 2010; 44(7-8):1314-8. PubMed ID: 20501891
[TBL] [Abstract][Full Text] [Related]
7. FDA approves new upgraded Gardasil 9.
Kirby T
Lancet Oncol; 2015 Feb; 16(2):e56. PubMed ID: 25532625
[No Abstract] [Full Text] [Related]
8. Assessing the HPV vaccine: researchers confront complex interplay of factors.
Tuma RS
J Natl Cancer Inst; 2009 Apr; 101(7):444-5. PubMed ID: 19318636
[No Abstract] [Full Text] [Related]
9. A human papillomavirus vaccine.
Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):65-6. PubMed ID: 16977280
[TBL] [Abstract][Full Text] [Related]
10. Who should get the HPV vaccine? Usage expands amid debate.
Peres J
J Natl Cancer Inst; 2010 Jun; 102(12):838-40. PubMed ID: 20530765
[No Abstract] [Full Text] [Related]
11. FDA approves Gardasil 9 for more types of HPV.
Printz C
Cancer; 2015 Apr; 121(8):1156-7. PubMed ID: 25855331
[No Abstract] [Full Text] [Related]
12. Merck hopes to extend gardasil vaccine to men.
Chitale R
J Natl Cancer Inst; 2009 Feb; 101(4):222-3. PubMed ID: 19211446
[No Abstract] [Full Text] [Related]
13. HPV vaccine: immersed in controversy.
Ohri LK
Ann Pharmacother; 2007 Nov; 41(11):1899-902. PubMed ID: 17848419
[TBL] [Abstract][Full Text] [Related]
14. The new human papilloma vaccine.
Macomber K; Vranesich P
Mich Nurse; 2007; 80(2):14. PubMed ID: 17503673
[No Abstract] [Full Text] [Related]
15. New quadrivalent HPV vaccine developments.
Tovar JM; Bazaldua OV
Postgrad Med; 2008 Nov; 120(4):14-6. PubMed ID: 19020361
[TBL] [Abstract][Full Text] [Related]
16. The HPV vaccine: a major public health breakthrough.
Gerbert D;
JAAPA; 2007 Mar; 20(3):17-8. PubMed ID: 17416019
[No Abstract] [Full Text] [Related]
17. HPV prevention update. New vaccine offers additional options.
Klisz C; Kaplan C
Adv Nurse Pract; 2009 Nov; 17(11):28-9, 54. PubMed ID: 20014688
[No Abstract] [Full Text] [Related]
18. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
Chaturvedi AK
J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus vaccine: an updated position statement of the Society for Adolescent Health and Medicine.
Friedman L; Bell DL; Kahn JA; Marcell AV; Middleman AB; Rosenthal SL; Zimet GD
J Adolesc Health; 2011 Feb; 48(2):215-6. PubMed ID: 21257124
[No Abstract] [Full Text] [Related]
20. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid.
Cook RL; Zhang J; Mullins J; Kauf T; Brumback B; Steingraber H; Mallison C
J Adolesc Health; 2010 Dec; 47(6):596-9. PubMed ID: 21094437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
